Users

Revive Therapeutics Announces FDA Acceptance of Meeting Request for Long COVID Diagnostic Product

Psychedelics20 hours ago

Cybin Announces Publication of Research Manuscript in the Journal of Medicinal Chemistry

Psychedelics20 hours ago

Clearmind signs agreement with Hebrew University for psychedelic compound rights

Law & Regulation1 day ago

Are Shrooms Legal in Oregon: Full Guide

Psilocybin2 days ago

Atai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of Psychopharmacology

Psychedelics2 days ago

Cybin Announces Grant of Additional U.S. Patent in Support of its CYB003 Breakthrough Therapy Program for Major Depressive Disorder

Psychedelics3 days ago

Psyence Group’s NASDAQ Listed Associate, Psyence Biomedical Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial

Psychedelics3 days ago

Optimi Health Achieves Milestone: Completes In-House Production of MDMA Active Pharmaceutical Ingredient (API)

Psychedelics3 days ago

Going concern warnings cloud Xtacy Therapeutics’ shrunk losses

Law & Regulation3 days ago

Numinus reports declining revenue as the company restructures

Law & Regulation4 days ago